Aarti pharma labs promoter Mr. Mirik Rajendra Gogri has disclosed the creation of a pledge on company shares under SEBI regulations. The disclosure, submitted on March 31, 2026, pertains to the pledging of shares for personal borrowing purposes under Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Pledge Details and Structure

The pledge involves 27,84,094 shares of Aarti Pharmalabs Limited, representing 3.08% of the company's total share capital. The encumbrance was created on March 25, 2026, in favor of two financial entities for third party pledge purposes.

Beneficiary Entities and Distribution

The pledged shares have been distributed between two financial institutions. Bajaj Financial Securities Limited received the larger portion with 26,16,700 shares, while 360 One Distribution Services Limited received 1,67,394 shares.

Financial Terms and Security Cover

The borrowing arrangement involves ₹75,00,00,000 against the pledged shares valued at ₹177,90,36,066 on the agreement date. This provides substantial security coverage for the lenders with a security cover ratio of 2.37.

Promoter Shareholding Context

As of December 31, 2025, Mr. Mirik Rajendra Gogri held 3,90,66,368 shares representing 43.10% of Aarti Pharmalabs Limited's total share capital. The current pledge represents 7% of his total promoter shareholding, which falls below the significant threshold levels requiring additional regulatory scrutiny.

The disclosure confirms that both beneficiary entities are recognized financial institutions, and the encumbrance is not related to any debt instruments such as debentures or commercial papers. The pledge arrangement follows standard regulatory compliance requirements under SEBI regulations for substantial acquisition of shares and takeovers.

Aarti pharma labs has disclosed the creation of a pledge by promoter Mr. Renil Rajendra Gogri involving 15,19,919 shares of the company. The disclosure was made under Regulation 31(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, dated March 31, 2026.

Pledge Details and Financial Institutions

The pledge was created on March 25, 2026, in favor of three financial institutions. The encumbered shares represent 1.68% of the company's total share capital and have been pledged for personal use by the promoter.

Distribution Among Financial Institutions

The pledged shares have been distributed among three financial institutions in varying proportions. Aditya Birla Capital Limited received 3,19,919 shares (0.35% of share capital), while Bajaj Financial Securities Limited received 6,00,000 shares (0.66% of share capital). The remaining 6,00,000 shares were allocated to 360 One Distribution Services Limited.

Promoter Shareholding Context

As of December 31, 2025, the total promoter shareholding in Aarti Pharmalabs Limited stood at 3,90,66,368 shares, representing 43.10% of the total share capital. The current pledge represents 3.89% of the promoter's total shareholding in the company.

Regulatory Compliance

The encumbered shares constitute less than 50% of the promoter shareholding and less than 20% of the total share capital, ensuring compliance with regulatory thresholds. The disclosure confirms that all three entities in whose favor the shares have been pledged are recognized financial institutions, including scheduled commercial banks, public financial institutions, or NBFCs.

Key Highlights

• The pledge does not relate to any debt instruments such as debentures or commercial papers
• All regulatory disclosures have been made to both NSE and BSE
• The transaction is classified as a third-party pledge for personal use
• The digital signature on the disclosure was executed on April 2, 2026
• The company's shares are listed on both National Stock Exchange of India Limited and BSE Limited